LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 166

Search options

  1. Article ; Online: NCOA3, a new player in melanoma susceptibility and a therapeutic target.

    Bezrookove, Vladimir / Kashani-Sabet, Mohammed

    Cancer gene therapy

    2022  Volume 29, Issue 5, Page(s) 399–401

    MeSH term(s) Humans ; Melanoma/genetics ; Melanoma/therapy ; Nuclear Receptor Coactivator 3
    Chemical Substances NCOA3 protein, human (EC 2.3.1.48) ; Nuclear Receptor Coactivator 3 (EC 2.3.1.48)
    Language English
    Publishing date 2022-03-23
    Publishing country England
    Document type Editorial ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 1212513-1
    ISSN 1476-5500 ; 0929-1903
    ISSN (online) 1476-5500
    ISSN 0929-1903
    DOI 10.1038/s41417-022-00449-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Extended long-term follow-up of metastatic melanoma patients treated with immunotherapy: late relapses and second primary melanomas.

    Minor, David R / Kim, Kevin B / Karuturi, R Krishna M / Kashani-Sabet, Mohammed

    Frontiers in oncology

    2023  Volume 13, Page(s) 1241917

    Abstract: Background: Immunotherapy has revolutionized the treatment of patients with advanced melanoma as well as other cancers. Most studies, whether of interleukin-2 or checkpoint inhibitor therapies, have limited follow-up after 5 years, making the incidence ... ...

    Abstract Background: Immunotherapy has revolutionized the treatment of patients with advanced melanoma as well as other cancers. Most studies, whether of interleukin-2 or checkpoint inhibitor therapies, have limited follow-up after 5 years, making the incidence of late relapses uncertain. In addition, the incidence of second primary melanomas in patients with stage IV melanoma treated with immunotherapy has rarely been reported.
    Methods: We performed a single-institution retrospective study of stage IV melanoma patients treated with interleukin-2 or checkpoint inhibitors over the period from 1992 to 2013. We found 59 patients alive and in remission 5 years after the beginning of immunotherapy and reviewed their subsequent clinical course.
    Results: This 59-patient cohort had a median follow-up of 13.1 years, with 36 patients followed up for at least 10 years. Four patients (6.8%) had relapses of their metastatic melanoma at 5, 8, 15, and 17 years after starting the successful immunotherapy. Three of the four are still alive. Only one patient in 690 patient-years of observation had a second primary invasive melanoma.
    Conclusion: Although late relapses after immunotherapy for melanoma do occur, we can conclude that the prognosis of stage IV melanoma patients in continuous remission 5 years after starting immunotherapy is excellent, with a progression-free survival of approximately 85% and a melanoma-specific survival of approximately 95% at 20 years in our series. Our incidence of second primary melanomas is lower than usually reported. These results have important implications regarding the follow-up of stage IV melanoma patients successfully treated with immunotherapy.
    Language English
    Publishing date 2023-12-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2023.1241917
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Nanometer-scale distribution of PD-1 in the melanoma tumor microenvironment.

    Comerci, Colin J / McCarthy, Dannielle G / Nosrati, Mehdi / Kim, Kevin B / Kashani-Sabet, Mohammed / Moerner, W E / Leong, Stanley P

    Journal of radiology and oncology

    2023  Volume 7, Issue 1, Page(s) 20–25

    Abstract: The nanometer-scale spatial organization of immune receptors plays a role in cell activation and suppression. While the connection between this spatial organization and cell signaling events is emerging from cell culture experiments, how these results ... ...

    Abstract The nanometer-scale spatial organization of immune receptors plays a role in cell activation and suppression. While the connection between this spatial organization and cell signaling events is emerging from cell culture experiments, how these results translate to more physiologically relevant settings like the tumor microenvironment remains poorly understood due to the challenges of high-resolution imaging
    Language English
    Publishing date 2023-05-10
    Publishing country United States
    Document type Journal Article
    ISSN 2573-7724
    ISSN (online) 2573-7724
    DOI 10.29328/journal.jro.1001048
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The Molecular Evolution of Melanoma Distant Metastases.

    Bezrookove, Vladimir / Kianian, Sara / McGeever, Lea / Jones, Robyn / Caressi, Chongshan / Nosrati, Mehdi / Kim, Kevin B / Leong, Stanley P / Miller, James R / Desprez, Pierre-Yves / Kashani-Sabet, Mohammed

    The Journal of investigative dermatology

    2024  

    Abstract: The evolution of primary melanoma to lymph node and distant metastasis is incompletely understood. We examined the genomic diversity in melanoma progression in matched primary melanomas and lymph node and distant metastases from 17 patients. FISH ... ...

    Abstract The evolution of primary melanoma to lymph node and distant metastasis is incompletely understood. We examined the genomic diversity in melanoma progression in matched primary melanomas and lymph node and distant metastases from 17 patients. FISH analysis revealed cancer cell fractions with monotonic copy number alterations, including PHIP gain and PTEN loss, in the metastatic cascade. By contrast, the cancer cell fraction with copy number alterations for BPTF and MITF was reduced in lymph node metastases but increased in distant metastases. Separately, the cancer cell fraction with NCOA3 copy number alteration was comparable between primary tumors and lymph node metastases yet increased in distant metastases. These results suggest enrichment of the phosphoinositide 3-kinase and MITF pathways in the transition through the metastatic cascade. By contrast, next-generation sequencing analysis did not identify a consistent pattern of changes in variant allele frequency while revealing several intriguing findings, including decreased variant allele frequency in distant metastases and distinct drivers in lymph node versus distant metastases. These results provide evidence that distant melanoma metastasis does not always emanate from lymph node metastasis. These results enhance our understanding of clonal patterns of melanoma metastasis, with possible implications for targeted therapy and metastasis competency.
    Language English
    Publishing date 2024-04-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80136-7
    ISSN 1523-1747 ; 0022-202X
    ISSN (online) 1523-1747
    ISSN 0022-202X
    DOI 10.1016/j.jid.2024.03.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: PHIPing along: Evolution of PHIP as a cancer biomarker and a target for therapy.

    Kashani-Sabet, Mohammed / Bezrookove, Vladimir / de Semir, David

    Oncotarget

    2018  Volume 9, Issue 90, Page(s) 36055–36056

    Language English
    Publishing date 2018-11-16
    Publishing country United States
    Document type Editorial
    ZDB-ID 2560162-3
    ISSN 1949-2553 ; 1949-2553
    ISSN (online) 1949-2553
    ISSN 1949-2553
    DOI 10.18632/oncotarget.26341
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Significant Clinical Response to a MEK Inhibitor Therapy in a Patient With Metastatic Melanoma Harboring an

    Kim, Kevin B / Semrad, Thomas / Schrock, Alexa B / Ali, Siraj M / Ross, Jeffrey S / Singer, Mark / Kashani-Sabet, Mohammed

    JCO precision oncology

    2022  Volume 2, Page(s) 1–6

    Language English
    Publishing date 2022-01-27
    Publishing country United States
    Document type Journal Article
    ISSN 2473-4284
    ISSN (online) 2473-4284
    DOI 10.1200/PO.17.00138
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target.

    Bezrookove, Vladimir / Khan, Imran A / Nosrati, Mehdi / Miller, James R / McAllister, Sean / Dar, Altaf A / Kashani-Sabet, Mohammed

    Frontiers in oncology

    2022  Volume 12, Page(s) 1011173

    Abstract: Purpose: To assess the biomarker and functional role of the chromatin remodeling factor, bromodomain PHD finger transcription factor (BPTF), in breast cancer progression.: Methods: BPTF: Results: BPTF: Conclusion: These studies demonstrate BPTF ...

    Abstract Purpose: To assess the biomarker and functional role of the chromatin remodeling factor, bromodomain PHD finger transcription factor (BPTF), in breast cancer progression.
    Methods: BPTF
    Results: BPTF
    Conclusion: These studies demonstrate BPTF activation in distinct breast cancer subtypes, identify pathways by which BPTF promotes breast cancer progression, and suggest BPTF as a rational target for breast cancer therapy.
    Language English
    Publishing date 2022-11-30
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2022.1011173
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Immunohistochemical diagnostic and prognostic markers for melanoma.

    Nosrati, Mehdi / Kashani-Sabet, Mohammed

    Methods in molecular biology (Clifton, N.J.)

    2014  Volume 1102, Page(s) 259–273

    Abstract: Recent studies in our laboratory have identified novel molecular diagnostic and prognostic markers based on analyses in large cohorts of melanoma patients. These markers were initially derived from gene expression profiling analyses of distinct stages of ...

    Abstract Recent studies in our laboratory have identified novel molecular diagnostic and prognostic markers based on analyses in large cohorts of melanoma patients. These markers were initially derived from gene expression profiling analyses of distinct stages of melanoma progression. Immunohistochemical analyses confirmed the differential expression of these markers, and immunohistochemistry-based multimarker assays were developed to assess melanoma diagnosis and prognosis at the molecular level. In this chapter we review the development of these assays and the methodologies used to assess marker expression in both nevi and primary melanomas.
    MeSH term(s) Antigens, Neoplasm/metabolism ; Biomarkers, Tumor/metabolism ; Humans ; Immunohistochemistry/methods ; Melanoma/diagnosis ; Melanoma/metabolism ; Neoplasm Proteins/metabolism ; Skin Neoplasms/diagnosis ; Skin Neoplasms/metabolism ; Solutions
    Chemical Substances Antigens, Neoplasm ; Biomarkers, Tumor ; Neoplasm Proteins ; Solutions
    Language English
    Publishing date 2014
    Publishing country United States
    Document type Journal Article
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-62703-727-3_14
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Tumor progression by immune evasion in melanoma: role of the programmed cell death-1/programmed cell death-1 ligand 1 interaction.

    Kashani-Sabet, Mohammed

    Cancer

    2010  Volume 116, Issue 7, Page(s) 1623–1625

    MeSH term(s) Antigens, CD/physiology ; Apoptosis Regulatory Proteins/physiology ; B7-H1 Antigen ; Biomarkers, Tumor/analysis ; CD8-Positive T-Lymphocytes/immunology ; Disease Progression ; Immune Evasion ; Melanoma/immunology ; Melanoma/pathology ; Prognosis ; Programmed Cell Death 1 Receptor
    Chemical Substances Antigens, CD ; Apoptosis Regulatory Proteins ; B7-H1 Antigen ; Biomarkers, Tumor ; CD274 protein, human ; PDCD1 protein, human ; Programmed Cell Death 1 Receptor
    Language English
    Publishing date 2010-04-01
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 1429-1
    ISSN 1097-0142 ; 0008-543X ; 1934-662X
    ISSN (online) 1097-0142
    ISSN 0008-543X ; 1934-662X
    DOI 10.1002/cncr.24909
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Complete clinical response to intralesional talimogene laherparepvec injection in a patient with recurrent, regionally advanced Merkel cell carcinoma.

    Nguyen, Michael H K / Leong, Stanley P / Abendroth, Roy / Kashani-Sabet, Mohammed / Kim, Kevin B

    JAAD case reports

    2019  Volume 5, Issue 10, Page(s) 849–851

    Language English
    Publishing date 2019-09-24
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2834220-3
    ISSN 2352-5126
    ISSN 2352-5126
    DOI 10.1016/j.jdcr.2019.07.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top